Pharma: a tale of rising demand and squeezed prices

Download the Document

Pharmaceuticals Sector Risk Report


Spending on prescription drugs is on an upward trajectory worldwide, and especially in Western Europe and the US. Pharma group profits rose by 2.9% in 2017. Reasons include ageing populations, changing lifestyles and pressure to access innovative treatments, and the rise comes despite the efforts of governments to control healthcare spending. The US situation is particularly uncertain, with the Trump administration’s attempts to repeal ‘Obamacare’ meeting difficulties.


Coface Regional Sector Risk Assessment

Strengths and weaknesses

Coface analysts predict research and development by pharmaceutical companies to pick up in 2018, and for prescription sales to grow – by 4% France, UK, Germany, Italy and Spain for example. This is driven by the rise in specialist drugs, which now amount to over a third of the total. Everywhere pharmaceutical companies are under pressure to provide discounts and lower prices by governments facing increasing demand. In the US alone, health insurance costs are likely to rise by as much as 18% in 2018.

Throughout the world healthcare provision is in flux and prices are being driven down. That’s why any company dealing with the pharma sector needs to have the best business data and insight on tap. It all comes free when you’re a Coface credit insurance policy holder.

Sign up for the latest news


Country Risk Assessment Map – Q2 2018

Our latest Country Risk Assessment Map for 2018 puts 160 countries under the microscope. Understand business default risk worldwide.

View Resource

Agrofood Sector Risk Report

Generally, worldwide food prices stabilised in 2017, having been exceptionally high before. For example, sugar prices, always volatile, fell sharply in 2017 after steep rises in the previous year.

View Resource

Transport Sector Risk Report

The recent trend has been for a sustained drop in prices being paid for transport around the world. But strong demand for air transport, which grew by 4% in 2017, is the big story in global transport.

View Resource